IBM Plans to Teach Watson How to Sift Through Medical Images and Diagnose Diseases – MIT Technology Review
IBM says that Watson, its artificial-intelligence…
Read More
Nominations Open: Be the Buzz of BIO at the BIO Investor Forum
Announcing the Buzz of BIO: Recognizing…
Read More
Gliknik Licensee Pfizer Receives Orphan Drug Designation From U.S. Food and Drug Administration For Drug Candidate Directed Towards Rare Neurological Disorder
Gliknik Inc., a privately held biopharmaceutical…
Read More
Epigenomics AG: Epigenomics and BioChain Announce the Inclusion of their Proprietary Blood-based Septin9 Test in the Chinese Screening Guideline for Colorectal Cancer
Epigenomics AG (Frankfurt Prime Standard: ECX,…
Read More
MedImmune licenses cervical, head and neck cancer vaccine from Inovio Pharmaceuticals – Washington Business Journal
Gaithersburg-based biotech MedImmune entered an exclusive…
Read More
Vasoptic Medical gets $250K investment from Abell Foundation – Technical.ly Baltimore
Bye bye, ‘burbs. Vasoptic Medical is officially…
Read More
Mobile health called ‘powerful equalizer’ for health disparitiesMedCity News
Mobile health tools will be “a…
Read More
EDA Announces $10M for Innovation Capacity-Building Activities; SSTI to Host Free Webinar on 2015 RIS Competition – SSTI
Secretary of Commerce Penny Pritzker announced…
Read More
Inviting Comments and Suggestions on the NIH-wide Strategic Plan
In response to a request from…
Read More
Symbiomix Therapeutics’ First Pivotal Trial Results for SYM-1219 for Bacterial Vaginosis Presented at IDSOG – FirstWord Pharma
Positive results of Symbiomix Therapeutics' first…
Read More
MedImmune, Mirati to conduct Phase I/II immuno-oncology combination trial to treat lung cancer – Pharmaceutical Business Review
MedImmune, a global biologics R&D arm…
Read More
Emergent BioSolutions Announces Plan to Implement Tax-Free Spin-Off of Biosciences Business Into a Separate Publicly-Traded Company NYSE:EBS
Emergent BioSolutions Inc. (NYSE:EBS) today announced…
Read More